Suheung

서흥 · 008490

Materials Chemicals · KOSPI

Small-cap

Market cap US$158.1M (₩218.2B)

Overview

Suheung makes hard capsules, the two-piece shell casings used to hold powdered or granular medicines and supplements, as well as soft capsules, functional health foods, and basic cosmetics, and it also produces gelatin and collagen as raw materials.

Its customers include pharmaceutical companies and health-supplement brands that rely on it for capsule supply and contract manufacturing. Listed on KOSPI, Korea's main stock exchange, the company holds a dominant position in the domestic hard-capsule market and is among the leading hard-capsule suppliers globally.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$523.4M
▲ +10.6% YoY
Operating profit · FY2025
US$36.4M
▲ +48.3% YoY
Net income · FY2025
US$34.2M
▲ +118.7% YoY

Revenue

  • FY2023US$430.8M
  • FY2024US$473.4M
  • FY2025US$523.4M

Operating profit

  • FY2023US$31.2M
  • FY2024US$24.5M
  • FY2025US$36.4M

Net income

  • FY2023US$6.4M
  • FY2024US$15.6M
  • FY2025US$34.2M

Key ratios (FY2025)

ROE
8.7%
Debt/Eq
96.1%
Op. margin
7.0%
Net margin
6.5%
Rev. YoY
▲ +10.6%

Why it matters

The hard-capsule division is Suheung's core business and accounts for the bulk of its activity, with the company also performing full-process contract manufacturing for soft-capsule drug formulations on behalf of pharmaceutical clients.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.